These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 274175

  • 1. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
    Lauzon GJ, Paterson AR, Belch AW.
    Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175
    [Abstract] [Full Text] [Related]

  • 2. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
    Lauzon GJ, Paran JH, Paterson AR.
    Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174
    [Abstract] [Full Text] [Related]

  • 3. 1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.
    Kucera GL, Capizzi RL.
    Cancer Res; 1992 Jul 15; 52(14):3886-91. PubMed ID: 1377599
    [Abstract] [Full Text] [Related]

  • 4. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 5. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B, Capizzi RL, Kute TE, Morgan T, Dimling J.
    Cancer Res; 1989 Jun 15; 49(12):3259-66. PubMed ID: 2720678
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT, Craig RW, Agarwal RP.
    Cancer Res; 1980 Sep 15; 40(9):3286-92. PubMed ID: 7427943
    [Abstract] [Full Text] [Related]

  • 12. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC, Hutchinson DJ, Schmid FA, Philips FS.
    Cancer Res; 1975 Jan 15; 35(1):225-36. PubMed ID: 1109791
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E, Eiferman F.
    J Clin Invest; 1979 Sep 15; 64(3):788-97. PubMed ID: 288743
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA, Morgenstern B, Capizzi RL.
    Cancer Res; 1982 Jun 15; 42(6):2191-7. PubMed ID: 7074600
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy of mouse leukemia L1210 by 1-beta-D-arabinofuranosylcytosine and 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine.
    Cass CE, Muzik H, Paterson AR.
    Cancer Res; 1975 May 15; 35(5):1187-93. PubMed ID: 1120308
    [Abstract] [Full Text] [Related]

  • 18. Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors.
    Rustum YM.
    Cancer Res; 1978 Mar 15; 38(3):543-9. PubMed ID: 203383
    [No Abstract] [Full Text] [Related]

  • 19. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F, Cadman E.
    Cancer Res; 1983 Jun 15; 43(6):2688-93. PubMed ID: 6189585
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Jan 15; 44(1):172-7. PubMed ID: 6690034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.